Logo

Tm Bioscience Approves More Stock Options

Dec 22, 1998
Premium

TORONTO--Tm Bioscience here, which designs, develops, and commercializes DNA products for bioinformatics, functional genomics, and other uses, has auth orized the issuance of an additional 340,000 stock purchase op tions, subject to approval by the Vancouver Stock Exchange. The options vest over four years and expire on August 26, 2001. They have been awarded to recently appointed executives and employees.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.